Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer
NCT00257348Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Mar 2004
- Primary completion
- Jul 2007
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, docetaxel in Cervical Cancer (CC), sponsored by University of California, Irvine. Started Mar 2004; status: completed.
02
Drugs
capecitabinedocetaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00257348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257348.